Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Unusual Options Activity in Johnson & Johnson Post Its Kenvue Spinoff Highlights Its Value

An unusual number of out-of-the-money put options in Johnson & Johnson come after the Aug. 30 spinoff of its consumer Kenvue business. This could be a good income play for short-put traders.

Barchart

About the new drug pricing negotiations

The first eligible drugs treat diabetes, blood clots, blood cancers, arthritis and heart disease

Salon

5 things consumers need to know about Medicare’s new drug-pricing negotiations, how they’ll affect you

This could help people whose Medicare drug plans require big copayments. But the main relief will come from part of the Inflation Reduction Act that caps drug spending by Medicare recipients at $2,000 a year starting in 2025.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Cost of tuberculosis treatment halved in deal to permit generic versions

Johnson & Johnson’s year-long deal on life-saving drug bedaquiline is seen as critical move in campaign against disease

The Guardian - UK

Is Johnson & Johnson (JNJ) a Buy Before September Begins?

Pharma giant Johnson & Johnson (JNJ) has posted robust second-quarter results and raised its full-year outlook. Should investors look into the stock before September begins? Let’s look at its financial metrics to gauge its prospects….

StockNews.com

Kenvue Joins S&P 500 on Friday: Time to Buy?

S&P Dow Jones Indices announced on Monday that Kenvue would join the S&P 500 on Friday. Tuesday’s volume and rising share price suggest that investors feel now is the time to buy its stock.

Barchart

'Private Tyranny' Is Less Private Than You Think

Sohrab Ahmari inadvertently gives even more reasons to reduce the power of the state.

Reason

Read news from The Economist, FT, and more,
with one subscription

Newly released FBI tapes show suspect suggesting how Tylenol murders were carried out

In the 2008 footage James Lewis is seen going into detail about how the Tylenol killer would have carried out the poisonings

The Independent UK

Is Johnson & Johnson (JNJ) a Must-Buy Stability Stock?

Thanks to the company’s solid first-quarter performance and growing pharmaceutical demand, Johnson & Johnson’s (JNJ) long-term prospects look bright. However, could the company ensure stability for investors amid the current market volatility? Keep reading….

StockNews.com

S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken

Paramount and Disney, along with AI play Adobe, led the S&P 500. Dexcom and several medical products firms struggled.

Investors Business Daily

Stocks Mixed, Jobs Data On Deck, Johnson & Johnson, Walmart, Yellow

Stock futures mixed amid 'soft landing' hopes for U.S. economy; Week Ahead: jobs data in focus, earnings reports accelerate; Johnson & Johnson slides as talc bankruptcy plan rejected by judge; Walmart buys out Tiger Global, expands Flipkart stake and Yellow slides as Teamsters say trucking giant preparing for bankruptcy.

The Street

Newest Fortune 500 member says large companies lose focus: 'You are little more remote from where the action is'

Kenvue, spun off from Johnson & Johnson in May, generated $15 billion in sales last year, enough to put it at rank 275 on 2022's Fortune 500 list.

Fortune

Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review

The Dow Jones lead the market rally, while Tesla, Netflix and Taiwan Semiconductor hit growth stocks Thursday.

Investors Business Daily

Johnson & Johnson Stock Just Got A Surprising New Price Target

Here's what may happen to J&J's shares next.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

J&J Stock Roars Higher, Retaking Its 200-Day Line As Small Drugs Drive Big Beat

Johnson & Johnson beat quarterly expectations Thursday, helped by its new cancer drug Carvykti, and JNJ stock surged.

The Street

Johnson & Johnson Earnings Top Forecasts On Solid Medical Device Sales

“We are entering the back half of the year from a position of strength with numerous catalysts, including becoming a two-sector company focused on Pharmaceutical and MedTech innovation," said CEO Joaquin Duato.

The Street

Stocks Mixed, Tesla, Netflix, Johnson & Johnson, United Airlines

Stock futures mixed as tech sector outlooks dim; Tesla shares slide as Elon Musk signals more EV price cuts; Netflix slumps as blowout subscriber numbers can't offset revenue miss; Johnson & Johnson earnings on deck following Kenvue spin-off and United Airlines shares higher after solid Q2 earnings, outlook lift.

The Hindu

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India

MSF reiterated its call for Johnson & Johnson to publicly announce that it will not enforce any ‘secondary’ patents for bedaquiline in any country with a high burden of TB, as J&J’s 20-year primary patent on bedaquiline expired on July 18.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Nine 'Safer Than AT&T' Stocks Pay The Plumpest, Lead-Free Dividends

AT&T's plump dividend used to be like money in the bank. But now investors seeking income and safety might look elsewhere.

The Guardian - UK

Cheaper TB drugs for millions after global deal on patent rights agreed

Johnson & Johnson allows generic bedaquiline in 44 countries – but concerns remain about ‘stopgap’ solution

The Independent UK

Johnson and Johnson shares licence for tuberculosis drug after novelist’s viral campaign

Disease kills millions each year even though it’s curable

Salon

Is Tylenol linked to autism and ADHD?

The debate over how to interpret acetaminophen science has profound implications for individuals and the public

The Independent UK

Seven murders by cyanide-laced Tylenol will never be solved. But the prime suspect’s death brings justice

After a joint FBI task force was unable to pin the 1982 Tylenol murders on prime suspect James Lewis, special agent Roy Lane was coaxed out of retirement to carry out a daring undercover mission. He tells Bevan Hurley Lewis’ death this week ‘puts the pursuit of justice to an…

Chicago Sun-Times

James Lewis, prime suspect in Tylenol tampering cases, dead at 76

James Lewis was found unresponsive at his residence in Cambridge, Mass. His death was determined to be not suspicious, police said.

Investors Business Daily

Seven Of The Top 10 Most-Valuable Stocks Are Still Cheap, Analysts Say

Think you missed your chance to profit on the S&P 500's most valuable stocks? Good news: analysts say there's still upside for most of them.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.